Abstract
Mechanoreciprocity refers to a cell’s ability to maintain tensional homeostasis in response to various types of forces. Physical forces are continually being exerted upon cells of various tissue types, even those considered static, such as the brain. Through mechanoreceptors, cells sense and subsequently respond to these stimuli. These forces and their respective cellular responses are prevalent in regulating everything from embryogenic tissue-specific differentiation, programmed cell death, and disease progression, the last of which being the subject of extensive attention. Abnormal mechanical remodeling of cells can provide clues as to the pathological status of tissues. This becomes particularly important in cancer cells, where cellular stiffness has been recently accepted as a novel biomarker for cancer metastasis. Several studies have also elucidated the importance of cell stiffness in cancer metastasis, with data highlighting that a reversal of tumor stiffness has the capacity to revert the metastatic properties of cancer. In this review, we summarize our current understanding of extracellular matrix (ECM) homeostasis, which plays a prominent role in tissue mechanics. We also describe pathological disruption of the ECM, and the subsequent implications toward cancer and cancer metastasis. In addition, we highlight the most novel approaches toward understanding the mechanisms which generate pathogenic cell stiffness and provide potential new strategies which have the capacity to advance our understanding of one of human-kinds’ most clinically significant medical pathologies. These new strategies include video-based techniques for structural dynamics, which have shown great potential for identifying full-field, high-resolution modal properties, in this case, as a novel application.
Keywords: cancer biology, biomarkers, metastasis and actin dynamics, cell rigidity measurement, cell morphodynamics
Introduction
Cancer is defined as a set of diseases in which cells bypass the mechanisms that normally limit their growth and replication capacity (Hanahan and Weinberg, 2000; Brower, 2007). This uncontrolled growth is characterized by overexpression of oncogenes, coupled with the loss of tumor suppressor genes (Hanahan and Weinberg, 2000). Eventually, this uncontrolled replication is followed by the invasion of nearby or distant tissue (Hanahan and Weinberg, 2000). Metastasis, or the spreading of a secondary cancer via the translocation of cancer cells to different parts of the body, is the cause of over 90% of human cancer deaths (Weigelt et al., 2005; Brower, 2007). This stark percentage highlights the importance of understanding the metastatic processes in cancer and the need to explore and elucidate more effective treatment options. These efforts are currently hindered by many factors, one of them being that a tumor’s microenvironment imparts anti-cancer drug resistance (Lin et al., 2017), making a tumor’s milieu an attractive area of study in the search for novel and unique anti-cancer strategies. Although, several environmental factors have been shown to increase the risk of cancer development (Evanthia et al., 2012; Di Ciaula et al., 2017), it is well known that the human genome plays a crucial role (Thean et al., 2017; Wilson et al., 2017; Gooskens et al., 2018) suggesting that future studies most employ a holistic approach in both the undertaking and subsequent interpretation.
Microenvironments and Mechanical Cell Signaling
Over the last 30 years, studies have emerged which highlight the effect of mechanical signals on cell behavior (Dupont et al., 2011; Wei et al., 2015; Lachowski et al., 2017). These signals, which emerge from the cells’ microenvironment are influenced by a wide variety of physical forces, including blood flow, gravity, muscle contractions and tissue rigidity (Butcher et al., 2009; Discher et al., 2009; Jaalouk and Lammerding, 2009; Panciera et al., 2017). The prevalence of physical forces, and its implications are observed in a range of fields spanning embryology, physiology as well as pathology. For example, mechanical force has been implicated in directing embryonic development (Farge, 2003; Ruiyi et al., 2006; Page-McCaw et al., 2007; Krieg et al., 2008). Studies show that force is necessary for proper tissue organization. Mesenchymal stem cells differentiate to lineages based on the specific composition of its surrounding matrix (Engler et al., 2006).
Extracellular Matrix Composition and Cancer Progression
It is clear that the ECM balances forces that maintain tissue homeostasis. The ECM is a dynamic, 3-dimensional, non-cellular structure that is constantly undergoing remodeling in response to mechanical and genetic cues (Bateman et al., 2009; Figure 1). ECM is composed of over 300 different proteins, all in compositional homeostasis, regulating respective structure and function, the precise configuration of which varies with tissue type (Hynes and Naba, 2012). The ECM comprises both the interstitium, as well as the basement membrane, and in this capacity is poised to be in constant interactions with epithelial cells. These interactions enable signal transduction processes which potentially regulate cell health/survival, apoptosis, migration and cell division among many others functions (Hynes, 2009; Hynes and Naba, 2012; Mushtaq et al., 2018; van Helvert et al., 2018). The main structural component of the ECM are collagens- which provide tensile strength and limit distensibility (Hynes and Naba, 2012). Other components include varying types of proteoglycans and glycoproteins, which include elastin (Hynes and Naba, 2012). Additional noteworthy components of the ECM are lysyl oxidase and hydroxylase (LOX and LOXL) (Kirschmann et al., 2002; Payne et al., 2007; Nilsson et al., 2016; Esposito et al., 2018). These secreted copper-dependent amine oxidases function to cross-link collagen and elastin, enabling them to play key roles in tumor progression and metastasis (Nilsson et al., 2016; Esposito et al., 2018). Indeed, many studies have outlined the effects and mechanism of action of LOX/LOXL in a myriad of oncogenic settings (Palamakumbura et al., 2009; Barker et al., 2012; Cox et al., 2016).
The importance of maintenance of ECM biophysical properties can be extrapolated from studies showing that inappropriate alterations are associated with fibrotic conditions and metastatic cancer. Indeed, it is well recognized that the ECM of a tumor is largely distinct from its counterpart in healthy cells (Aszódi et al., 2006; Cox and Erler, 2011; Sotgia et al., 2012; Leight et al., 2017). Studies which outline how post-translational cross-linking of the ECM in premalignant breast cancer is a necessary step for transformation into a malignant cancer suggest that the ECM’s biochemical composition is of paramount importance in cancer progression in this response (Paszek et al., 2005; Levental et al., 2009). This highly impactful data underscores the significance of ECM homeostasis and highlights the necessity to better understand the mechanism(s) that drive ECM remodeling in the context of oncology.
From Mechanical to Molecular
The topology and rigidity of the extracellular matrix (ECM) is used as a counterbalancing external force against internal pulling forces (Vogel and Sheetz, 2006). Cell structure appears to be regulated by cycles of mechano-sensing, mechano-transduction and mechano-response; where a local sensing of spatial geometry is translated into biochemical cues which can eventually control cell growth, differentiation, shape changes and cell death as previously mentioned (Vogel and Sheetz, 2006). It is through this mechanism that macroscopic cues reach the microscopic scale, regulating cell fate through the modulation of gene expression.
Thus, it is now well established that mechanical cues comprise an integral part of both normal and abnormal physiology, or pathology (Jaalouk and Lammerding, 2009). However, the mechanism(s) by which such cues are translated into molecular signals which subsequently drive increases in gene expression are unclear. Given that cells can perceive their position and shape by interpreting such mechanical cues, it is not surprising that any missteps in the translation of such signals can also lead to abnormalities such as cancer. Understanding the molecular mechanisms involved in this process can thus provide strategies for the identification and treatment of cancer. The focus of this manuscript will be on mechano-transducing transcriptional co-activators, changes in whose expression can potentially mediate the development of cancer.
Mechano-Transducing Transcriptional Co-Activators in Cancer
Yes-associated protein (YAP) and transcriptional co-activator with PDZ binding motif (TAZ), are oncogenic transcriptional co-regulators which are part of the Hippo pathway, and have recently been identified as mechano-transducing transcriptional co-activators (Panciera et al., 2017). YAP/TAZ have been tightly linked to actin cytoskeleton architecture, promoting cancer drug resistance through actin remodeling; by interacting with transcriptional enhancer factor TEF-1, also known as TEA domain family member (TEAD). These transcription factors are able to translate mechanical cues such as ECM rigidity into genomic transcriptional changes which can then promote processes such as stem cell behavior and regeneration (Kim et al., 2016; Panciera et al., 2017). This translational regulation is mediated via Rho GTPase activity, making YAP/TAZ necessary for the ECM stiffness-mediated mesenchymal stem cell differentiation described earlier (Deng et al., 2006; Dupont et al., 2011). Mechanical stimuli and tension create force-dependent mechanical restriction, which results in the inhibition of nuclear pores for molecular transport, thereby directly driving YAP nuclear translocation (Elosegui-Artola et al., 2017). YAP and TAZ are thus re-localized into the nucleus in cells that experience enhanced signaling from processes such as cytoskeletal tension, or increased stretch (Elosegui-Artola et al., 2017), resulting in YAP-dependent and TAZ-dependent biological effects, including cell proliferation (Aragona et al., 2013). In addition, results suggest that the restriction of transport/translocation is further regulated via the addition of mechanical stability, a property which the transported protein exhibits (Elosegui-Artola et al., 2017). This determines both the active and passive nuclear transport of YAP, as well as other proteins (Elosegui-Artola et al., 2017). YAP and TAZ are thus necessary for uncontrolled cell proliferation, overcoming contact inhibition, and consequently, are very important in cancer development and metastasis (Kanellos et al., 2015; Zanconato et al., 2016). The microenvironment of tumors is known to impart specific mechanical inputs, which are a consequence of aberrant tissue organization, metalloproteinase-mediated ECM remodeling and ECM stiffening (Tang et al., 2013), which in turn induce YAP and TAZ overactivity in cancer cells. ECM remodeling and stiffening are interesting candidates of study in the understanding of YAP- and TAZ-mediated conversion of benign neoplastic cells into cancer stem cells. Intrinsically, cells appear to be tumor-suppressive, and while remaining in relatively unagitated mechanical conditions, experience low mechanical forces, which leads to low levels of YAP/TAZ. However, in disturbed tissue architecture ECM stiffening induces YAP/TAZ activation/nuclear translocation (Finch-Edmondson and Sudol, 2016; Wang et al., 2016). Recent published studies have validated that active nuclear import indeed controls YAP localization by using AFM as a means for force application on nuclei, results of which suggest that increased active nuclear import is the mediator of YAP nuclear translocation when force is applied both directly as well as indirectly (Elosegui-Artola et al., 2017).
The mechanism linking tissue rigidity and YAP/TAZ-mediated uncontrolled proliferation in tumor cells is not well understood, and offers possible new research targets against epithelial mesenchymal transition (EMT). For example, it is still not clear whether the development of cancer results in mechanical stimuli which induces YAP activity or whether Yap induction contributes to the reorganization, however it is likely that both scenarios are possible, one being driven by genetic predispositions for example, while the other, likely environmental. EMT is a cellular process by which immotile epithelial cells are converted into motile mesenchymal cells via the degradation of the underlying basement membrane. In normal cells, epithelial cells tightly adhere to the basement membrane, which is thus responsible for holding the cells in place (Yang and Weinberg, 2008). The transformation of epithelial cells to motile mesenchymal cells is characterized by the attainment of migratory capacity, invasiveness, resistance to apoptosis and increased ECM production leading to cell rigidity (Kalluri and Weinberg, 2009).
A critical element of EMT is an actin-dependent protrusion of cell pseudopodia; resulting in the destabilization of the actin cytoskeleton, which is a key component of EMT-driven cancer metastasis (Shankar et al., 2010). Known mesenchymal cell markers included FTS binding protein FAP, FSP-1, N-cadherin, vimentin, fibronectin, and β- catenin, among others (Kalluri and Weinberg, 2009; Fernandez-Garcia et al., 2014). Given that YAP is a regulator of these markers, it is not surprising that EMT is promoted by YAP overexpression (Yuan et al., 2016). Recent studies have affirmed that cytoskeleton stability plays an important role in cancer metastasis, given its association with EMT (Sun et al., 2015). Understanding the physical interplay of this intracellular filament network, and its real-time contribution to cancer metastasis is an intriguing therapeutic target against cancer, and the focus of our research. Studies to date have focused on actin cytoskeleton reorganization using live cell imaging and GFP-coronin, as an F-actin reporter (Mun and Jeon, 2012). In a study investigating the relationship of matrix stiffness in EMT, it was found that in genetically engineered pancreatic cancers, fibrotic rigidities promote elements of EMT (Rice et al., 2017). Pancreatic cancer is one of the stiffest of all human solid carcinomas (Rice et al., 2017). Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by the presence of extensive desmoplasia and myofibroblast-like, high matrix secreting phenotype (Lachowski et al., 2017). Stiffness is also an associated finding in other cancers. For instance, in breast cancer ECM stiffness induces EMT through mechano-transduction, leading to nuclear translocation of YAP and TAZ (Dupont et al., 2011; Wei et al., 2015). In HER2-amplified breast cancer cells, fibronectin, type IV collagen, and matrix rigidity all contribute to drug resistance as tumor microenvironments modulate and dampen the efficacy of targeted anti-cancer therapies (Allen and Louise Jones, 2011; Lin et al., 2017).
Bridging the Gap – New Methods Toward Understanding the Cellular Biophysics in Cancer
There is a need for more sensitive techniques in order to address the gaps in this field; current research aims are to develop and use sensitive image analyses techniques for quantitatively characterizing structural dynamics at the cellular level- specifically, in cells undergoing cancer metastasis. There still exists significant gaps in quantitatively analyzing the data from current techniques, and in using them to verify and validate finite element models describing the mechanics of cells. This is primarily because of the lack of comprehensive techniques to measure the full-field structural stiffness of cells. With its resolution in the order of fractions of a nanometer, atomic force microscopy (AFM) is one of many methods currently being evaluated in order to obtain high-resolution imaging of cell surface topography as it offers the convenience of being able to measure forces and elasticity in fixed and living cells (Naitoh et al., 2010; Garcia and Proksch, 2013). Applications thus far have included the study of cellular events including locomotion, differentiation and aging, physiological activation and electromotility, as well as cell pathology (Lekka et al., 1999; Nagayama et al., 2001; Müller and Dufrêne, 2011). Bimodal force microscopy uses AFM with several eigenmode excitations frequencies which can be detected, allowing the different resonances to act as channels, which can then be used to isolate material properties such as Young’s modulus of elasticity (a measure of stiffness) (Rodrìguez and Garcìa, 2004; Proksch, 2006). The detection of the cantilever interaction with the sample is monitored and translated into a three-dimensional image (Mozafari et al., 2005), which can reveal heterogeneities of mechanical properties of both the surface and subsurface of cells (Kuznetsova et al., 2007). The methods so far discussed have allowed us to gain preliminary insight into the contribution of mechanical signals and changes in the development and propagation of cancer. However, even with AFM, there are limitations such as the addition of unwanted background flow modes from piezoelectric shakers (Guan et al., 2017). Additionally, AFM sensitivity significantly decreases when probing properties in a liquid medium, given that frequency modulation and dual-frequency imaging are designed for operation in air (Minary-Jolandan et al., 2012). Recently, this limitation has been averted with a unique technique which images cells using AFM with a long-needle probe using only the tip of the probe as the point of interaction with a liquid medium, and spares the cantilever’s high-quality resonant modes by maintaining its air-functioning quality and providing non-contact viscoelastic imaging of living cells (Guan et al., 2017). AFM interrogation of YAP/TAZ has shown that force application to the nucleus is enough to enable YAP translocation independent of rigidity, focal adhesions, the actin cytoskeleton, and also cell-cell adhesion using a constant force of 1.5 nN to the cell nucleus, using cantilevers with 20-μm spherical tips (Elosegui-Artola et al., 2017). In addition, force application to the nucleus increased the nuclear/cytosolic YAP ratio, and then proceeded to return to baseline levels when the force was withdrawn, suggesting that force disrupts YAP distribution and that the observed equilibrium lasts only while force is being applied (Elosegui-Artola et al., 2017). Additionally, it should be noted that these studies have found that there were no measurable differences in YAP ratios when the probe was used to press outside the nucleus, suggesting that the forces produced by exposure to a stiff environment are exerted through focal adhesions and are thereby able to reach the nucleus (Elosegui-Artola et al., 2017). Lastly, because a force- induced breakage of the nucleocytoplasmic barrier cannot be responsible for such an immediate nuclear export, it rules out the possibility that these translocation are simply due to high nuclear deformations (Elosegui-Artola et al., 2017).
Another interesting non-contact/non-intrusive imaging method currently used for diagnostic purposes is interferometric phase microscopy (IPM), which provides several advantages over AFM (Bishitz et al., 2014). The appeal of IPM is that it captures the entire amplitude and phase data from the optical illumination of the sample, generating an optical thickness fluctuation map, which indicates rigidity strength for every cell in the field of view (Bishitz et al., 2014), with the added benefit of cell to cell comparison. However, even as we circumvent existing limitations and find novel techniques that increase imaging sensitivity, it is imperative to note that we are only beginning to understand the relationship between biophysical properties of cells, and their potential to regulate tumorigenesis and motility (Paszek and Weaver, 2004). There is a need for novel and unique imaging techniques develop that provide verification and validation of finite element models of cellular structure.
Author Contributions
BM devised the project, the main conceptual ideas to be explored, and manuscript outline, worked out the technical details of the review, and performed the literature review and data gathering. All authors contributed substantial context addition, editing and revision of all drafts.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Footnotes
Funding. BM was supported by a Director’s post-doctoral fellowship under the Laboratory Directed Research and Development program of the Los Alamos National Laboratory under project number 20170694PRD4. YY was partially supported by the U.S. Defense Advanced Research Projects Agency (DARPA) “Physics of AI” program.
References
- Allen M., Louise Jones J. (2011). Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J. Pathol. 223 163–177. 10.1002/path.2803 [DOI] [PubMed] [Google Scholar]
- Aragona M., Panciera T., Manfrin A., Giulitti S., Michielin F., Elvassore N., et al. (2013). A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154 1047–1059. 10.1016/j.cell.2013.07.042 [DOI] [PubMed] [Google Scholar]
- Aszódi A., Legate K. R., Nakchbandi I., Fässler R. (2006). What mouse mutants teach us about extracellular matrix function. Annu. Rev. Cell Dev. Biol. 22 591–621. 10.1146/annurev.cellbio.22.010305.104258 [DOI] [PubMed] [Google Scholar]
- Barker H. E., Cox T. R., Erler J. T. (2012). The rationale for targeting the LOX family in cancer. Nat. Rev. Cancer 12 540–552. 10.1038/nrc3319 [DOI] [PubMed] [Google Scholar]
- Bateman J. F., Boot-Handford R. P., Lamandé S. R. (2009). Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat. Rev. Genet. 10 173–183. 10.1038/nrg2520 [DOI] [PubMed] [Google Scholar]
- Bishitz Y., Gabai H., Girshovitz P., Shaked N. T. (2014). Optical-mechanical signatures of cancer cells based on fluctuation profiles measured by interferometry. J. Biophoton. 7 624–630. 10.1002/jbio.201300019 [DOI] [PubMed] [Google Scholar]
- Brower V. (2007). Researchers tackle metastasis, cancer’s last frontier. J. Natl. Cancer Inst. 99 109–111. 10.1093/jnci/djk047 [DOI] [PubMed] [Google Scholar]
- Butcher D. T., Alliston T., Weaver V. M. (2009). A tense situation: forcing tumour progression. Nat. Rev. Cancer 9 108–122. 10.1038/nrc2544 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cox T. R., Erler J. T. (2011). Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis. Models Mech. 4 165–178. 10.1242/dmm.004077 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cox T. R., Gartland A., Erler J. T. (2016). Lysyl oxidase, a targetable secreted molecule involved in cancer metastasis. Cancer Res. 76 188–192. 10.1158/0008-5472.CAN-15-2306 [DOI] [PubMed] [Google Scholar]
- Deng J., Petersen B. E., Steindler D. A., Jorgensen M. L., Laywell E. D. (2006). Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells 24 1054–1064. 10.1634/stemcells.2005-0370 [DOI] [PubMed] [Google Scholar]
- Di Ciaula A., Wang D. Q.-H., Molina-Molina E., Baccetto R. L., Calamita G., Palmieri V. O., et al. (2017). Bile acids and cancer: direct and environmental-dependent effects. Ann. Hepatol. 16 81–99. [DOI] [PubMed] [Google Scholar]
- Discher D. E., Mooney D. J., Zandstra P. W. (2009). Growth factors, matrices, and forces combine and control stem cells. Science 324 1673–1677. 10.1126/science.1171643 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dupont S., Morsut L., Aragona M., Enzo E., Giulitti S., Cordenonsi M., et al. (2011). Role of YAP/TAZ in mechanotransduction. Nature 474 179–183. 10.1038/nature10137 [DOI] [PubMed] [Google Scholar]
- Elosegui-Artola A., Andreu I., Beedle A. E. M., Lezamiz A., Uroz M., Kosmalska A. J., et al. (2017). Force triggers YAP nuclear entry by regulating transport across nuclear pores. Cell 171 1397.e14–1410.e14. 10.1016/j.cell.2017.10.008 [DOI] [PubMed] [Google Scholar]
- Engler A. J., Sen S., Sweeney H. L., Discher D. E. (2006). Matrix elasticity directs stem cell lineage specification. Cell 126 677–689. 10.1016/j.cell.2006.06.044 [DOI] [PubMed] [Google Scholar]
- Esposito P., Estienne L., Serpieri N., Ronchi D., Comi G. P., Moggio M., et al. (2018). Rhabdomyolysis-associated acute kidney injury. Am. J. Kidney Dis. 71 A12–A14. [DOI] [PubMed] [Google Scholar]
- Evanthia D.-K., Charikleia C., Evangelos M. (2012). Phenotypes and enviromental factors: their influence in PCOS. Curr. Pharmaceut. Design 18 270–282. 10.2174/138161212799040457 [DOI] [PubMed] [Google Scholar]
- Farge E. (2003). Mechanical induction of twist in the Drosophila Foregut/Stomodeal Primordium. Curr. Biol. 13 1365–1377. 10.1016/s0960-9822(03)00576-1 [DOI] [PubMed] [Google Scholar]
- Fernandez-Garcia B., Eiró N., Marín L., González-Reyes S., González L. O., Lamelas M. L., et al. (2014). Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis. Histopathology 64 512–522. 10.1111/his.12300 [DOI] [PubMed] [Google Scholar]
- Finch-Edmondson M., Sudol M. (2016). Framework to function: mechanosensitive regulators of gene transcription. Cell. Mol. Biol. Lett. 21:28. 10.1186/s11658-016-0028-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garcia R., Proksch R. (2013). Nanomechanical mapping of soft matter by bimodal force microscopy. Eur. Polym. J. 49 1897–1906. 10.1016/j.eurpolymj.2013.03.037 [DOI] [Google Scholar]
- Gooskens S. L., Klasson T. D., Gremmels H., Logister I., Pieters R., Perlman E. J., et al. (2018). TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration. Mol. Oncol. 12 166–179. 10.1002/1878-0261.12149 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guan D., Charlaix E., Qi R. Z., Tong P. (2017). Noncontact viscoelastic imaging of living cells using a long-needle atomic force microscope with dual-frequency modulation. Phys. Rev. Appl. 8:044010. [Google Scholar]
- Hanahan D., Weinberg R. A. (2000). The hallmarks of cancer. Cell 100 57–70. [DOI] [PubMed] [Google Scholar]
- Hynes R. O. (2009). Extracellular matrix: not just pretty fibrils. Science 326 1216–1219. 10.1126/science.1176009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hynes R. O., Naba A. (2012). Overview of the Matrisome—An inventory of extracellular matrix constituents and functions. Cold Spring Harb. Perspect. Biol. 4:a004903. 10.1101/cshperspect.a004903 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jaalouk D. E., Lammerding J. (2009). Mechanotransduction gone awry. Nat. Rev. Mol. Cell Biol. 10 63–73. 10.1038/nrm2597 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kalluri R., Weinberg R. A. (2009). The basics of epithelial-mesenchymal transition. J. Clin. Investig. 119 1420–1428. 10.1172/JCI39104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kanellos G., Zhou J., Patel H., Ridgway Rachel A., Huels D., Gurniak Christine B., et al. (2015). ADF, and cofilin1 control actin stress fibers, nuclear integrity, and cell survival. Cell Rep. 13 1949–1964. 10.1016/j.celrep.2015.10.056 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim M. H., Kim J., Hong H., Lee S. H., Lee J. K., Jung E., et al. (2016). Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation. EMBO J. 35 462–478. 10.15252/embj.201592081 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kirschmann D. A., Seftor E. A., Fong S. F. T., Nieva D. R. C., Sullivan C. M., Edwards E. M., et al. (2002). A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 62 4478–4483. [PubMed] [Google Scholar]
- Krieg M., Arboleda-Estudillo Y., Puech P. H., Käfer J., Graner F., Müller D. J., et al. (2008). Tensile forces govern germ-layer organization in zebrafish. Nat. Cell Biol. 10 429–436. 10.1038/ncb1705 [DOI] [PubMed] [Google Scholar]
- Kuznetsova T. G., Starodubtseva M. N., Yegorenkov N. I., Chizhik S. A., Zhdanov R. I. (2007). Atomic force microscopy probing of cell elasticity. Micron 38 824–833. 10.1016/j.micron.2007.06.011 [DOI] [PubMed] [Google Scholar]
- Lachowski D., Cortes E., Pink D., Chronopoulos A., Karim S. A., Morton J. P., et al. (2017). Substrate rigidity controls activation and durotaxis in pancreatic stellate cells. Sci. Rep. 7:2506. 10.1038/s41598-017-02689-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leight J. L., Drain A. P., Weaver V. M. (2017). Extracellular matrix remodeling and stiffening modulate tumor phenotype and treatment response. Annu. Rev. Cancer Biol. 1 313–334. 10.1146/annurev-cancerbio-050216-034431 [DOI] [Google Scholar]
- Lekka M., Laidler P., Gil D., Lekki J., Stachura Z., Hrynkiewicz A. Z. (1999). Elasticity of normal and cancerous human bladder cells studied by scanning force microscopy. Eur. Biophys. J. 28 312–316. 10.1007/s002490050213 [DOI] [PubMed] [Google Scholar]
- Levental K. R., Yu H., Kass L., Lakins J. N., Egeblad M., Erler J. T., et al. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139 891–906. 10.1016/j.cell.2009.10.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin C.-H., Jokela T., Gray J., LaBarge M. A. (2017). Combinatorial microenvironments impose a continuum of cellular responses to a single pathway-targeted anti-cancer compound. Cell Rep. 21 533–545. 10.1016/j.celrep.2017.09.058 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Minary-Jolandan M., Tajik A., Wang N., Yu M.-F. (2012). Intrinsically high-Q dynamic AFM imaging in liquid with a significantly extended needle tip. Nanotechnology 23 235704–235704. 10.1088/0957-4484/23/23/235704 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mozafari M. R., Reed C. J., Rostron C., Hasirci V. (2005). A review of scanning probe microscopy investigations of liposome-DNA complexes. J. Liposome Res. 15 93–107. 10.1081/lpr-200064965 [DOI] [PubMed] [Google Scholar]
- Müller D. J., Dufrêne Y. F. (2011). Atomic force microscopy: a nanoscopic window on the cell surface. Trends Cell Biol. 21 461–469. 10.1016/j.tcb.2011.04.008 [DOI] [PubMed] [Google Scholar]
- Mun H., Jeon T. J. (2012). Regulation of actin cytoskeleton by Rap1 binding to RacGEF1. Mol. Cells 34 71–76. 10.1007/s10059-012-0097-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mushtaq M. U., Papadas A., Pagenkopf A., Flietner E., Morrow Z., Chaudhary S. G., et al. (2018). Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers. J. Immunother. Cancer 6:65. 10.1186/s40425-018-0376-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nagayama M., Haga H., Kawabata K. (2001). Drastic change of local stiffness distribution correlating to cell migration in living fibroblasts. Cell Motil. Cytoskeleton 50 173–179. 10.1002/cm.10008 [DOI] [PubMed] [Google Scholar]
- Naitoh Y., Ma Z., Li Y. J., Kageshima M., Sugawara Y. (2010). Simultaneous observation of surface topography and elasticity at atomic scale by multifrequency frequency modulation atomic force microscopy. J. Vac. Sci. Technol. B Nanotechnol. Microelectron. 28 1210–1214. 10.1116/1.3503611 [DOI] [Google Scholar]
- Nilsson M., Adamo H., Bergh A., Halin Bergström S. (2016). Inhibition of lysyl oxidase and lysyl oxidase-like enzymes has tumour-promoting and tumour-suppressing roles in experimental prostate cancer. Sci. Rep. 6:19608. 10.1038/srep19608 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Page-McCaw A., Ewald A. J., Werb Z. (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8 221–233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Palamakumbura A. H., Vora S. R., Nugent M. A., Kirsch K. H., Sonenshein G. E., Trackman P. C. (2009). Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. Oncogene 28 3390–3400. 10.1038/onc.2009.203 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Panciera T., Azzolin L., Cordenonsi M., Piccolo S. (2017). Mechanobiology of YAP and TAZ in physiology and disease. Nat. Rev. Mol. Cell Biol. 18 758–770. 10.1038/nrm.2017.87 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paszek M. J., Weaver V. M. (2004). The tension mounts: mechanics meets morphogenesis and malignancy. J. Mamm. Gland Biol. Neoplasia 9 325–342. 10.1007/s10911-004-1404-x [DOI] [PubMed] [Google Scholar]
- Paszek M. J., Zahir N., Johnson K. R., Lakins J. N., Rozenberg G. I., Gefen A., et al. (2005). Tensional homeostasis and the malignant phenotype. Cancer Cell 8 241–254. 10.1016/j.ccr.2005.08.010 [DOI] [PubMed] [Google Scholar]
- Payne S. L., Hendrix M. J. C., Kirschmann D. A. (2007). Paradoxical roles for lysyl oxidases in cancer—A prospect. J. Cell. Biochem. 101 1338–1354. 10.1002/jcb.21371 [DOI] [PubMed] [Google Scholar]
- Proksch R. (2006). Multifrequency, repulsive-mode amplitude-modulated atomic force microscopy. Appl. Phys. Lett. 89:113121 10.1063/1.2345593 [DOI] [Google Scholar]
- Rice A. J., Cortes E., Lachowski D., Cheung B. C. H., Karim S. A., Morton J. P., et al. (2017). Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells. Oncogenesis 6:e352. 10.1038/oncsis.2017.54 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rodrìguez T. R., Garcìa R. (2004). Compositional mapping of surfaces in atomic force microscopy by excitation of the second normal mode of the microcantilever. Appl. Phys. Lett. 84 449–451. 10.1063/1.1642273 [DOI] [Google Scholar]
- Ruiyi R., Martina N., Emilios T., Rudi W., Karen S. (2006). Migrating anterior mesoderm cells and intercalating trunk mesoderm cells have distinct responses to Rho and Rac during Xenopus gastrulation. Dev. Dyn. 235 1090–1099. 10.1002/dvdy.20711 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shankar J., Messenberg A., Chan J., Underhill T. M., Foster L. J., Nabi I. R. (2010). Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res. 70 3780–3790. 10.1158/0008-5472.CAN-09-4439 [DOI] [PubMed] [Google Scholar]
- Sotgia F., Martinez-Outschoorn U. E., Howell A., Pestell R. G., Pavlides S., Lisanti M. P. (2012). Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annu. Rev. Pathol. Mech. Dis. 7 423–467. 10.1146/annurev-pathol-011811-120856 [DOI] [PubMed] [Google Scholar]
- Sun B. O., Fang Y., Li Z., Chen Z., Xiang J. (2015). Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression. Biomed. Rep. 3 603–610. 10.3892/br.2015.494 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tang Y., Rowe R. G., Botvinick E. L., Kurup A., Putnam A. J., Seiki M., et al. (2013). MT1-MMP-dependent control of skeletal stem cell commitment via a β1-integrin/YAP/TAZ signaling axis. Dev. Cell 25 402–416. 10.1016/j.devcel.2013.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thean L. F., Low Y. S., Lo M., Teo Y.-Y., Koh W.-P., Yuan J.-M., et al. (2017). Genome-wide association study identified copy number variants associated with sporadic colorectal cancer risk. J. Med. Genet. 55 181–188. 10.1136/jmedgenet-2017-104913 [DOI] [PubMed] [Google Scholar]
- van Helvert S., Storm C., Friedl P. (2018). Mechanoreciprocity in cell migration. Nat. Cell Biol. 20 8–20. 10.1038/s41556-017-0012-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vogel V., Sheetz M. (2006). Local force and geometry sensing regulate cell functions. Nat. Rev. Mol. Cell Biol. 7 265–275. 10.1038/nrm1890 [DOI] [PubMed] [Google Scholar]
- Wang K.-C., Yeh Y.-T., Nguyen P., Limqueco E., Lopez J., Thorossian S., et al. (2016). Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 113 11525–11530. 10.1073/pnas.1613121113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wei S. C., Fattet L., Tsai J. H., Guo Y., Pai V. H., Majeski H. E., et al. (2015). Matrix stiffness drives Epithelial-Mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. Nat. Cell Biol. 17 678–688. 10.1038/ncb3157 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weigelt B., Peterse J. L., van’t Veer L. J. (2005). Breast cancer metastasis: markers and models. Nat. Rev. Cancer 5 591–602. 10.1038/nrc1670 [DOI] [PubMed] [Google Scholar]
- Wilson C. L., Mann D. A., Borthwick L. A. (2017). Epigenetic reprogramming in liver fibrosis and cancer. Adv. Drug Deliv. Rev. 121 124–132. 10.1016/j.addr.2017.10.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang J., Weinberg R. A. (2008). Epithelial-Mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14 818–829. 10.1016/j.devcel.2008.05.009 [DOI] [PubMed] [Google Scholar]
- Yuan Y., Li D., Li H., Wang L., Tian G., Dong Y. (2016). YAP overexpression promotes the epithelial-mesenchymal transition and chemoresistance in pancreatic cancer cells. Mol. Med. Rep. 13 237–242. 10.3892/mmr.2015.4550 [DOI] [PubMed] [Google Scholar]
- Zanconato F., Battilana G., Cordenonsi M., Piccolo S. (2016). YAP/TAZ as therapeutic targets in cancer. Curr. Opin. Pharmacol. 29 26–33. 10.1016/j.coph.2016.05.002 [DOI] [PMC free article] [PubMed] [Google Scholar]